We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$460M
AUM Growth
-$19.1M
Cap. Flow
-$3.4M
Cap. Flow %
-0.74%
Top 10 Hldgs %
71.83%
Holding
94
New
1
Increased
7
Reduced
8
Closed
8

Top Buys

Rank Stock Value
1
MIST icon
Milestone Pharmaceuticals
MIST
+$4.28M
2
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$2.7M
3
CUE icon
Cue Biopharma
CUE
+$934K
4
OPTN
OptiNose
OPTN
+$666K
5
GPGI
GPGI Inc
GPGI
+$281K

Top Sells

Rank Stock Value
1
TCDA
Tricida, Inc. Common Stock
TCDA
+$5.24M
2
LIN icon
Linde
LIN
+$3.76M
3
HCAR
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
+$1.49M
4
CELC icon
Celcuity
CELC
+$502K
5
BKTI icon
BK Technologies
BKTI
+$481K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.02%
2 Healthcare 18.61%
3 Miscellaneous 17.76%
4 Industrials 15.02%
5 Financials 13.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DUOT icon
26
Duos Technologies
DUOT
$294M
$2.57M 0.56%
1,283,162
– –
CUE icon
27
Cue Biopharma
CUE
$203M
$2.45M 0.53%
28,709
+10,209
+55% +$934K
BRIV
28
DELISTED
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
$2.24M 0.49%
225,000
– –
HLTH
29
DELISTED
Cue Health Inc. Common Stock
HLTH
$2.07M 0.45%
1,000,000
– –
LIQT icon
30
LiqTech
LIQT
$18.8M
$1.42M 0.31%
466,609
+56,250
+14% +$181K
LBTYK icon
31
Liberty Global Class C
LBTYK
$3.56B
$1.35M 0.29%
69,618
– –
MXCT icon
32
MaxCyte
MXCT
$126M
$1.32M 0.29%
250,000
– –
ONDS icon
33
Ondas Inc
ONDS
$4.51B
$1.23M 0.27%
775,000
– –
BRFH icon
34
Barfresh Food Group
BRFH
$20.4M
$1.04M 0.23%
800,287
+75,000
+10% +$135K
QUMU
35
DELISTED
Qumu Corp.
QUMU
$670K 0.15%
750,000
– –
ICCC icon
36
ImmuCell
ICCC
$90.3M
$620K 0.13%
101,594
– –
RTX icon
37
RTX Corp
RTX
$285B
$606K 0.13%
6,000
– –
ARKOW
38
DELISTED
ARKO Corp Warrant
ARKOW
$583K 0.13%
333,333
– –
VATE icon
39
INNOVATE Corp
VATE
$104M
$514K 0.11%
27,480
– –
LBTYA icon
40
Liberty Global Class A
LBTYA
$3.64B
$435K 0.09%
22,989
– –
FNCH
41
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$389K 0.08%
27,014
– –
PYPL icon
42
PayPal
PYPL
$45.9B
$377K 0.08%
5,300
– –
LHX icon
43
L3Harris
LHX
$48.9B
$333K 0.07%
1,600
– –
YEXT icon
44
Yext
YEXT
$693M
$283K 0.06%
43,263
-16,737
-28% -$91.3K
CARR icon
45
Carrier Global
CARR
$48.5B
$248K 0.05%
6,000
– –
OTIS icon
46
Otis Worldwide
OTIS
$27.3B
$235K 0.05%
3,000
– –
PHYS icon
47
Sprott Physical Gold
PHYS
$16B
$177K 0.04%
12,540
– –
CRIS icon
48
Curis
CRIS
$3.61M
$172K 0.04%
780
-312
-29% -$91.5K
INFI
49
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$139K 0.03%
250,000
– –
DNTH icon
50
Dianthus Therapeutics
DNTH
$5.92B
$137K 0.03%
21,664
-8,611
-28% -$152K
1
2
3 4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return

Bleichroeder LP's Q4 2022 Portfolio in Review

As of Q4 2022, Bleichroeder LP held 94 positions worth $460M, down 4% from $479M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Bleichroeder LP's Q4 2022 filing shows 1 new, 7 increased, 8 reduced and 8 closed positions. Its largest new stake was Xperi: 34 shares worth $293. The largest sale was Tricida, Inc. Common Stock, an estimated $5.24M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Miscellaneous.

  • Bleichroeder LP's largest Q4 2022 buy was Xperi: 34 shares worth $293.
  • Bleichroeder LP added most to Milestone Pharmaceuticals in Q4 2022, an estimated $4.28M increase.
  • Bleichroeder LP's biggest Q4 2022 reduction was Linde, cutting an estimated $3.76M.
  • Bleichroeder LP fully exited Tricida, Inc. Common Stock in Q4 2022, selling an estimated $5.24M.
  • Bleichroeder LP's ten largest holdings make up 72% of its $460M portfolio in Q4 2022.
  • Bleichroeder LP opened 1 new position and closed 8 in Q4 2022.
  • Bleichroeder LP's portfolio value fell 4% quarter-over-quarter to $460M.

Based on Bleichroeder LP's 13F filing for Q4 2022, filed 14 Feb 2023.